Insights

Delivering Quality and Performance to your Drug Discovery Research

Biophysical society annual meeting 2024

Biophysical society annual meeting 2024

Pennsylvania Convention Centre, February 10th-14th Engage with us at our exhibition booth Experience first-hand the breadth of our ion channel and receptor drug discovery capabilities by visiting us at booth 527. Join us at the Drug Discovery for Ion Channels XXIV...

read more
SfN- neuroscience 2023

SfN- neuroscience 2023

Washington, D.C, November 12th-15th This year marks the inaugural joint appearance of SB Drug Discovery, Sygnature Discovery, and NuChem Sciences at SfN's annual Neuroscience conference following the acquisition. Anticipate an excellent week ahead, featuring a stellar...

read more
Accelerating transporter drug discovery

Accelerating transporter drug discovery

SB Drug Discovery is excited to announce a significant advancement in its screening capabilities with the integration of the state-of-the-art SURFE2R 96SE. Enabling high throughput solid supported membrane-based electrophysiology and supporting critical lead...

read more
NuChem Sciences Acquisition

NuChem Sciences Acquisition

Sygnature Discovery accelerates global growth with major North American acquisition. Leading integrated drug discovery partner, Sygnature Discovery (“Sygnature”) has announced its acquisition of one of North America’s largest discovery Contract Research Organisations,...

read more
Sygnature acquisition

Sygnature acquisition

SYGNATURE DISCOVERY COMPLETES ACQUISITION OF SB DRUG DISCOVERY TO FURTHER STRENGTHEN THEIR MARKET-LEADING CAPABILITIES SB Drug Discovery is excited to announce that it has been acquired by Sygnature Discovery (Sygnature), a world leading integrated drug discovery...

read more
Skip to content